Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-030308

Executive VP, Global R&D sold 130,000 shares at $8.22 ($1,068,067)

From the SEC's structured data for this filing

Trades in this filing

Fridriksdottir Hafrun · Executive VP, Global R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-17 Sale : show line 1 in the form −130,000 $8.22 $1,068,067 1,386.51 D
Open-market sales · 130,000 sh · avg $8.22 · $1,068,067
Loading xslF345X03/doc4.xml…